Announcements
- Insider Information: Nexstim Plc Announces Planned Alzheimer’s Collaboration with Sinaptica Therapeutics, Inc.
- Sisäpiiritieto: Nexstim Oyj tiedottaa suunnitellusta yhteistyöstä Sinaptica Therapeutics, Inc:n kanssa Alzheimerin taudin hoidon alalla
- Finnish Hospital Orders Nexstim NBS System 5
- Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
- Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market
- Neurosurgery Customer from Germany Orders Nexstim NBS System 5
- Nexstim Plc Business Update Q1 2024
- Nexstim Oyj:n liiketoiminnan päivitys, tammi-maaliskuu 2024
- Nexstim Plc: Managers’ Transactions, Hildén
- Nexstim Oyj: Johdon liiketoimet, Hildén
More ▼
Key statistics
On Friday, Nexstim Oyj (5NX:MUN) closed at 2.80, 22.81% above the 52 week low of 2.28 set on Nov 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.80 |
---|---|
High | 2.80 |
Low | 2.80 |
Bid | 3.45 |
Offer | 3.73 |
Previous close | 2.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 6.77m |
Free float | 3.46m |
P/E (TTM) | -- |
Market cap | 18.94m EUR |
EPS (TTM) | -0.1956 EUR |
Data delayed at least 15 minutes, as of Jun 07 2024 07:10 BST.
More ▼